JPMorgan Chase & Co’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.32M | Buy |
57,258
+4,918
| +9% | +$200K | ﹤0.01% | 3238 |
|
2025
Q1 | $2.29M | Sell |
52,340
-300
| -0.6% | -$13.1K | ﹤0.01% | 3176 |
|
2024
Q4 | $2.26M | Buy |
52,640
+48,197
| +1,085% | +$2.07M | ﹤0.01% | 3312 |
|
2024
Q3 | $197K | Buy |
4,443
+1,182
| +36% | +$52.4K | ﹤0.01% | 4461 |
|
2024
Q2 | $130K | Buy |
3,261
+2,271
| +229% | +$90.3K | ﹤0.01% | 4478 |
|
2024
Q1 | $42.7K | Sell |
990
-8,133
| -89% | -$351K | ﹤0.01% | 5030 |
|
2023
Q4 | $380K | Buy |
9,123
+8,784
| +2,591% | +$366K | ﹤0.01% | 4057 |
|
2023
Q3 | $13.5K | Hold |
339
| – | – | ﹤0.01% | 5246 |
|
2023
Q2 | $13.9K | Sell |
339
-60
| -15% | -$2.46K | ﹤0.01% | 5114 |
|
2023
Q1 | $16K | Buy |
399
+60
| +18% | +$2.41K | ﹤0.01% | 5186 |
|
2022
Q4 | $14K | Hold |
339
| – | – | ﹤0.01% | 5056 |
|
2022
Q3 | $14K | Sell |
339
-103,959
| -100% | -$4.29M | ﹤0.01% | 5009 |
|
2022
Q2 | $4.38M | Buy |
104,298
+43,959
| +73% | +$1.85M | ﹤0.01% | 2480 |
|
2022
Q1 | $2.73M | Buy |
60,339
+32,581
| +117% | +$1.47M | ﹤0.01% | 2970 |
|
2021
Q4 | $1.28M | Buy |
27,758
+23,419
| +540% | +$1.08M | ﹤0.01% | 3523 |
|
2021
Q3 | $206K | Sell |
4,339
-29,604
| -87% | -$1.41M | ﹤0.01% | 4400 |
|
2021
Q2 | $1.76M | Sell |
33,943
-51,341
| -60% | -$2.66M | ﹤0.01% | 3297 |
|
2021
Q1 | $4.29M | Sell |
85,284
-213,173
| -71% | -$10.7M | ﹤0.01% | 2746 |
|
2020
Q4 | $15.5M | Sell |
298,457
-28,942
| -9% | -$1.51M | ﹤0.01% | 1621 |
|
2020
Q3 | $14.1M | Sell |
327,399
-82,367
| -20% | -$3.54M | ﹤0.01% | 1548 |
|
2020
Q2 | $17.6M | Sell |
409,766
-177,133
| -30% | -$7.61M | ﹤0.01% | 1322 |
|
2020
Q1 | $21.2M | Buy |
586,899
+586,765
| +437,884% | +$21.2M | 0.01% | 1117 |
|
2019
Q4 | $6K | Sell |
134
-1,126,369
| -100% | -$50.4M | ﹤0.01% | 4562 |
|
2019
Q3 | $40.1M | Buy |
1,126,503
+776,283
| +222% | +$27.6M | 0.01% | 965 |
|
2019
Q2 | $13.8M | Buy |
350,220
+250,000
| +249% | +$9.84M | ﹤0.01% | 1553 |
|
2019
Q1 | $4.17M | Sell |
100,220
-137,985
| -58% | -$5.74M | ﹤0.01% | 2207 |
|
2018
Q4 | $8.72M | Buy |
238,205
+119,122
| +100% | +$4.36M | ﹤0.01% | 1765 |
|
2018
Q3 | $5.78M | Buy |
119,083
+114,330
| +2,405% | +$5.55M | ﹤0.01% | 2160 |
|
2018
Q2 | $205K | Sell |
4,753
-2,732
| -36% | -$118K | ﹤0.01% | 3815 |
|
2018
Q1 | $313K | Sell |
7,485
-10,904
| -59% | -$456K | ﹤0.01% | 3560 |
|
2017
Q4 | $800K | Sell |
18,389
-83,330
| -82% | -$3.63M | ﹤0.01% | 3153 |
|
2017
Q3 | $4.29M | Buy |
101,719
+92,868
| +1,049% | +$3.92M | ﹤0.01% | 2251 |
|
2017
Q2 | $381K | Sell |
8,851
-20,736
| -70% | -$893K | ﹤0.01% | 3233 |
|
2017
Q1 | $1.24M | Buy |
29,587
+10,027
| +51% | +$419K | ﹤0.01% | 2808 |
|
2016
Q4 | $765K | Buy |
19,560
+1,263
| +7% | +$49.4K | ﹤0.01% | 3094 |
|
2016
Q3 | $809K | Buy |
18,297
+419
| +2% | +$18.5K | ﹤0.01% | 2837 |
|
2016
Q2 | $747K | Buy |
17,878
+4,763
| +36% | +$199K | ﹤0.01% | 2852 |
|
2016
Q1 | $528K | Buy |
13,115
+55
| +0.4% | +$2.21K | ﹤0.01% | 2895 |
|
2015
Q4 | $669K | Buy |
+13,060
| New | +$669K | ﹤0.01% | 2824 |
|
2015
Q3 | – | Sell |
-10,004
| Closed | -$623K | – | 3445 |
|
2015
Q2 | $623K | Buy |
+10,004
| New | +$623K | ﹤0.01% | 3006 |
|
2015
Q1 | – | Sell |
-8,594
| Closed | -$464K | – | 3526 |
|
2014
Q4 | $464K | Buy |
+8,594
| New | +$464K | ﹤0.01% | 3048 |
|